247 related articles for article (PubMed ID: 29440247)
1. KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis.
Lin-Shiao E; Lan Y; Coradin M; Anderson A; Donahue G; Simpson CL; Sen P; Saffie R; Busino L; Garcia BA; Berger SL; Capell BC
Genes Dev; 2018 Jan; 32(2):181-193. PubMed ID: 29440247
[TBL] [Abstract][Full Text] [Related]
2. Transcription factor p63 bookmarks and regulates dynamic enhancers during epidermal differentiation.
Kouwenhoven EN; Oti M; Niehues H; van Heeringen SJ; Schalkwijk J; Stunnenberg HG; van Bokhoven H; Zhou H
EMBO Rep; 2015 Jul; 16(7):863-78. PubMed ID: 26034101
[TBL] [Abstract][Full Text] [Related]
3. Role of chromatin and transcriptional co-regulators in mediating p63-genome interactions in keratinocytes.
Sethi I; Sinha S; Buck MJ
BMC Genomics; 2014 Nov; 15(1):1042. PubMed ID: 25433490
[TBL] [Abstract][Full Text] [Related]
4. ZNF185 is a p63 target gene critical for epidermal differentiation and squamous cell carcinoma development.
Smirnov A; Lena AM; Cappello A; Panatta E; Anemona L; Bischetti S; Annicchiarico-Petruzzelli M; Mauriello A; Melino G; Candi E
Oncogene; 2019 Mar; 38(10):1625-1638. PubMed ID: 30337687
[TBL] [Abstract][Full Text] [Related]
5. H3K4 mono- and di-methyltransferase MLL4 is required for enhancer activation during cell differentiation.
Lee JE; Wang C; Xu S; Cho YW; Wang L; Feng X; Baldridge A; Sartorelli V; Zhuang L; Peng W; Ge K
Elife; 2013 Dec; 2():e01503. PubMed ID: 24368734
[TBL] [Abstract][Full Text] [Related]
6. Mutant p63 Affects Epidermal Cell Identity through Rewiring the Enhancer Landscape.
Qu J; Tanis SEJ; Smits JPH; Kouwenhoven EN; Oti M; van den Bogaard EH; Logie C; Stunnenberg HG; van Bokhoven H; Mulder KW; Zhou H
Cell Rep; 2018 Dec; 25(12):3490-3503.e4. PubMed ID: 30566872
[TBL] [Abstract][Full Text] [Related]
7. Enhancer priming by H3K4 methyltransferase MLL4 controls cell fate transition.
Wang C; Lee JE; Lai B; Macfarlan TS; Xu S; Zhuang L; Liu C; Peng W; Ge K
Proc Natl Acad Sci U S A; 2016 Oct; 113(42):11871-11876. PubMed ID: 27698142
[TBL] [Abstract][Full Text] [Related]
8. KMT2D maintains neoplastic cell proliferation and global histone H3 lysine 4 monomethylation.
Guo C; Chen LH; Huang Y; Chang CC; Wang P; Pirozzi CJ; Qin X; Bao X; Greer PK; McLendon RE; Yan H; Keir ST; Bigner DD; He Y
Oncotarget; 2013 Nov; 4(11):2144-53. PubMed ID: 24240169
[TBL] [Abstract][Full Text] [Related]
9. Histone H3 lysine 4 methyltransferase KMT2D.
Froimchuk E; Jang Y; Ge K
Gene; 2017 Sep; 627():337-342. PubMed ID: 28669924
[TBL] [Abstract][Full Text] [Related]
10. KMT2D Deficiency Impairs Super-Enhancers to Confer a Glycolytic Vulnerability in Lung Cancer.
Alam H; Tang M; Maitituoheti M; Dhar SS; Kumar M; Han CY; Ambati CR; Amin SB; Gu B; Chen TY; Lin YH; Chen J; Muller FL; Putluri N; Flores ER; DeMayo FJ; Baseler L; Rai K; Lee MG
Cancer Cell; 2020 Apr; 37(4):599-617.e7. PubMed ID: 32243837
[TBL] [Abstract][Full Text] [Related]
11. The low-complexity domains of the KMT2D protein regulate histone monomethylation transcription to facilitate pancreatic cancer progression.
Li W; Wu L; Jia H; Lin Z; Zhong R; Li Y; Jiang C; Liu S; Zhou X; Zhang E
Cell Mol Biol Lett; 2021 Nov; 26(1):45. PubMed ID: 34758724
[TBL] [Abstract][Full Text] [Related]
12. DBC1 is a key positive regulator of enhancer epigenomic writers KMT2D and p300.
Kim HJ; Moon SJ; Hong S; Won HH; Kim JH
Nucleic Acids Res; 2022 Aug; 50(14):7873-7888. PubMed ID: 35801925
[TBL] [Abstract][Full Text] [Related]
13. Control of keratinocyte proliferation and differentiation by p63.
Truong AB; Khavari PA
Cell Cycle; 2007 Feb; 6(3):295-9. PubMed ID: 17264679
[TBL] [Abstract][Full Text] [Related]
14. Loss of MLL3/4 decouples enhancer H3K4 monomethylation, H3K27 acetylation, and gene activation during embryonic stem cell differentiation.
Boileau RM; Chen KX; Blelloch R
Genome Biol; 2023 Mar; 24(1):41. PubMed ID: 36869380
[TBL] [Abstract][Full Text] [Related]
15. Mll3 and Mll4 Facilitate Enhancer RNA Synthesis and Transcription from Promoters Independently of H3K4 Monomethylation.
Dorighi KM; Swigut T; Henriques T; Bhanu NV; Scruggs BS; Nady N; Still CD; Garcia BA; Adelman K; Wysocka J
Mol Cell; 2017 May; 66(4):568-576.e4. PubMed ID: 28483418
[TBL] [Abstract][Full Text] [Related]
16. Control of p53-dependent transcription and enhancer activity by the p53 family member p63.
Karsli Uzunbas G; Ahmed F; Sammons MA
J Biol Chem; 2019 Jul; 294(27):10720-10736. PubMed ID: 31113863
[TBL] [Abstract][Full Text] [Related]
17. Histone methyltransferase KMT2D sustains prostate carcinogenesis and metastasis via epigenetically activating LIFR and KLF4.
Lv S; Ji L; Chen B; Liu S; Lei C; Liu X; Qi X; Wang Y; Lai-Han Leung E; Wang H; Zhang L; Yu X; Liu Z; Wei Q; Lu L
Oncogene; 2018 Mar; 37(10):1354-1368. PubMed ID: 29269867
[TBL] [Abstract][Full Text] [Related]
18. Brd4 binds to active enhancers to control cell identity gene induction in adipogenesis and myogenesis.
Lee JE; Park YK; Park S; Jang Y; Waring N; Dey A; Ozato K; Lai B; Peng W; Ge K
Nat Commun; 2017 Dec; 8(1):2217. PubMed ID: 29263365
[TBL] [Abstract][Full Text] [Related]
19. Tumor-specific p73 up-regulation mediates p63 dependence in squamous cell carcinoma.
DeYoung MP; Johannessen CM; Leong CO; Faquin W; Rocco JW; Ellisen LW
Cancer Res; 2006 Oct; 66(19):9362-8. PubMed ID: 17018588
[TBL] [Abstract][Full Text] [Related]
20. Loss of KMT2D induces prostate cancer ROS-mediated DNA damage by suppressing the enhancer activity and DNA binding of antioxidant transcription factor FOXO3.
Lv S; Wen H; Shan X; Li J; Wu Y; Yu X; Huang W; Wei Q
Epigenetics; 2019 Dec; 14(12):1194-1208. PubMed ID: 31232159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]